An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer
- 30 November 2002
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 184 (5) , 414-417
- https://doi.org/10.1016/s0002-9610(02)01015-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumorsProceedings of the National Academy of Sciences, 2002
- Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?Breast Cancer Research and Treatment, 2001
- Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant TherapyJournal of Clinical Oncology, 2001
- Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic FactorsJournal of Clinical Oncology, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Classification of isolated tumor cells and micrometastasisCancer, 1999
- Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separationInternational Journal of Cancer, 1998
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991